Investor Relations

Investor Relations

Prospectus

Financial report

Announcement and Circular

Corporate Governance

Investor Inquiry

Voluntary announcement regarding the latest business situation of the Phase I clinical trial of 6B11-OCIK injection.

Release time：2021-03-12 08:04

  • File size: 226.0KB

Previous Page

Announcement and Notice - [Board Meeting Date]

Monthly report on the changes in securities of the issuer as of February 28, 2021.

Next Page

Previous Page

Announcement and Notice - [Board Meeting Date]

Next Page

Monthly report on the changes in securities of the issuer as of February 28, 2021.

Yongtai Biology

+86-10-88400295

www.eaal.net

Yongtai Biology

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Powered by 300.cn  Policy

Business License